Pharmaceutical Vials Market: Industry Trends and Global Forecasts - Distribution by Type of Fabrication Material Used, Sterilization Status and Key Geographies

List of Tables

PHARMACEUTICAL VIALS MARKET: OVERVIEW

As per Roots Analysis, the global pharmaceutical vials market valued at USD 11.03 billion in the current year is anticipated to grow at a CAGR of 6% during the forecast period.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Fabrication Material Used

Glass
Plastic

Sterilization Status

Pre-sterilized
Unsterilized

Key Geographies

North America
Europe
Asia- Pacific
Latin America
Middle East and North Africa
Rest of the World

PHARMACEUTICAL VIALS MARKET: GROWTH AND TRENDS

Primary packaging material such as pharmaceutical glass vials play a crucial role in preserving the stability, efficacy and safety of the drug as it is in direct contact with the packaged therapeutic. Additionally, pharmaceutical primary packaging material assists in maintaining the sterility and quality of a drug product, while also providing information related to its identity and, in certain cases, dosing instructions. Moreover, given the high demand for parenteral formulations and rising vaccination campaigns, there is an urgent need for safe and high-quality pharmaceutical vials, for storing and distributing such formulations in large quantities, across the world.

Despite being the most preferred packaging system, traditional vials are often associated with certain challenges, including chances of breakage under extreme conditions, absence of relevant information (serial or batch number) on the package and potential to delaminate. As a result, several pharmaceutical vials manufacturers are exploring novel techniques to overcome the aforementioned challenges associated with conventional pharmaceutical vials in order to create better packaging solutions. In fact, pharmaceutical vial manufacturers are constantly innovating and creating newer and better packaging solutions in order to meet the changing demands of next generation drug products. Examples of some advancements in this domain include the use of pre-sterilized vials, development of numerous coating materials and adoption of smart drug delivery technologies.

PHARMACEUTICAL VIALS MARKET: KEY INSIGHTS

The report delves into the current state of the global pharmaceutical vials market and identifies potential growth opportunities within industry. Some key findings from the report include:

Presently, more than 240 pharmaceutical vials are available / being developed by close to 95 manufacturers; most of these players are based in the developed such as North America and Europe.
Majority of the pharmaceutical vials are fabricated using glass and are available in a variety of volumes; screw caps are amongst the preferred type of vial caps used for such containers.

Owing to the various benefits, glass emerged as the most preferred fabrication material used for pharmaceutical vials; common types of glass used include type I borosilicate glass (65%) and type III soda-lime glass (16%).
Majority (60%) of the pharmaceutical vials have a capacity to hold less than 50 ml of drug product; however, very few (8%) vials are capable of storing more than 100 ml of therapeutic products.
More than 60% of the pharmaceutical vials are designed to be used with screw caps; examples of such vials include 1-Clic(R) Vial System, CryoClear(TM) vials, NextGen(TM) V-Vial(R), Pyrofree vials and Sterile CryoSure(R) Vial.
In pursuit of building a competitive edge, industry stakeholders are actively upgrading their existing capabilities and adding new competencies in order to enhance their respective product portfolios.
Over the years, industry players have established several deals to further advance the development / enable the improvement of their proprietary pharmaceutical vials.
The partnership activity in this domain has increased at a CAGR of over 30% in the past few years.
Both established players and new entrants have forged strategic partnerships in the recent past; acquisitions emerged as the prominent type of partnership model.
Current industry trends support the growing need for innovative packaging solutions, primarily to accommodate large scale and specialized production / packaging requirements of increasingly complex drug products.
Close to 40 players claim to provide a wide range of robotic machinery, having different degrees of freedom, offering notable productivity and cost optimization opportunities.
Pharmaceutical vials have been in high demand during the COVID-19 pandemic to store and package the novel vaccines and experimental therapies in large quantities.

The estimated market opportunity for pharmaceutical vials is expected to be well distributed across different types of fabrication material, sterilization status and geographical regions.

Example Players in the Pharmaceutical Vials Market

Chongqing Zhengchuan Pharmaceutical Packaging
Corning
DANYANG XIANGHE PHARMACEUTICAL PACKAGING
DWK Life Sciences
Gerresheimer
Ningbo Zhengli Pharmaceutical Packaging
Nipro
Origin Pharma Packaging
Pacific Vial Manufacturing
SCHOTT
SGD Pharma
Shandong Pharmaceutical Glass
Stevanato Group
Thermo Fisher Scientific
Worldwide Glass Resources

PHARMACEUTICAL VIALS MARKET: RESEARCH COVERAGE

Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the pharmaceutical vials market, focusing on key market segments, including [A] type of fabrication material used, [B] sterilization status and [C] key geographies.
Market Landscape: A comprehensive evaluation of pharmaceutical vials, based on several relevant parameters, such as [A] type of fabrication material used for container, [B] type of fabrication material used for closure, [C] volume of vial, [D] type of vial cap, [D] sterilization status, [E] type of product, [F] compatible drug class and [G] type of formulation stored. Additionally, a comprehensive evaluation of pharmaceutical vial manufacturers based on several relevant parameters, including [A] year of establishment, [B] company size, [C] location of headquarters and [D] key players (in terms of number of products).
Company Competitiveness Analysis: A comprehensive competitive analysis of pharmaceutical vial manufacturers, examining factors, such as [A] supplier power and [B] key product specifications.
Company Profiles: In-depth profiles of the players engaged in the development of pharmaceutical vials, focusing on [A] overview of the company, [B] financial information (if available), [C] product portfolio and [D] recent developments and an informed future outlook.
Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in the pharmaceutical vial domain, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] type of fabrication material involved, [D] sterilization status, [E] type of partners and [F] regional distribution of the partnerships.
Upcoming Trends in Pharmaceutical Packaging: An in-depth analysis of key trends that are likely to impact the future adoption of novel primary packaging systems. Further, a Harvey ball analysis, focusing on the relative effect of each trend on the overall pharmaceutical packaging industry.
Demand Analysis: A detailed analysis of the current and future demand for pharmaceutical vials, based on various parameters, such as [A] type of fabrication material used, [B] sterilization status and [C] regions.
Case Study: A detailed discussion on the use of robotic machinery in pharmaceutical manufacturing and fill / finish operations, describing the advantages of using automation / automated technologies in such processes.
Case Study: A detailed discussion on pre-sterilized / RTU pharmaceutical vials that are currently available. Additionally, the section discusses various sterilization techniques used for primary packaging materials and the advantages of RTU container-closure systems.

KEY QUESTIONS ANSWERED IN THIS REPORT

How many companies are currently engaged in this market?
Which are the leading companies in this market?
What factors are likely to influence the evolution of this market?
What is the current and future market size?
What is the CAGR of this market?
How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

Complimentary PPT Insights Packs
Complimentary Excel Data Packs for all Analytical Modules in the Report
15% Free Content Customization
Detailed Report Walkthrough Session with Research Team
Free Updated report if the report is 6-12 months old or older

Product Code: RA100302

1. PREFACE

1.1. Scope of the Report
1.2. Research Methodology
- 1.2.1. Research Assumptions
- 1.2.2. Project Methodology
- 1.2.3. Forecast Methodology
- 1.2.4. Robust Quality Control
- 1.2.5. Key Considerations
  - 1.2.5.1. Demographics
  - 1.2.5.2. Economic Factors
  - 1.2.5.3. Government Regulations
  - 1.2.5.4. Supply Chain
  - 1.2.5.5. COVID Impact / Related Factors
  - 1.2.5.6. Market Access
  - 1.2.5.7. Healthcare Policies
  - 1.2.5.8. Industry Consolidation
1.3 Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1. Chapter Overview
3.2. Pharmaceutical Packaging
- 3.2.1. Need for Pharmaceutical Packaging
- 3.2.2. Types of Pharmaceutical Packaging
3.3. Pharmaceutical Vials
- 3.3.1. Types of Fabrication Materials Used for Vials
  - 3.3.1.1. Glass Vials
  - 3.3.1.2. Plastic Vials
- 3.3.2. Vial Caps
3.4. Innovation in Pharmaceutical Vials

4. MARKET LANDSCAPE

4.1. Chapter Overview
4.2. Pharmaceutical Vials: Overall Market Landscape
- 4.2.1. Analysis by Type of Fabrication Material Used (Container)
- 4.2.2. Analysis by Type of Fabrication Material Used (Closure)
- 4.2.3. Analysis by Volume of Vial
- 4.2.4. Analysis by Type of Vial Cap
- 4.2.5. Analysis by Sterilization Status
- 4.2.6. Analysis by Type of Product
- 4.2.7. Analysis by Compatible Drug Class
- 4.2.8. Analysis by Type of Formulation Stored
4.3. Pharmaceutical Vials: List of Manufacturers
- 4.3.1. Analysis by Year of Establishment
- 4.3.2. Analysis by Company Size
- 4.3.3. Analysis by Location of Headquarters
- 4.3.4. Leading Manufacturers: Analysis by Number of Products

5. COMPANY COMPETITIVENESS ANALYSIS

5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Pharmaceutical Vials: Company Competitiveness Analysis
- 5.4.1. Company Competitiveness: Small Manufacturers
- 5.4.2. Company Competitiveness: Mid-sized Manufacturers
- 5.4.3. Company Competitiveness: Large Manufacturers
- 5.4.4. Company Competitiveness: Very Large Manufacturers

6. COMPANY PROFILES: PHARMACEUTICAL VIAL MANUFACTURERS IN NORTH AMERICA

6.1. Chapter Overview
6.2. Corning
- 6.2.1. Company Overview
- 6.2.2. Financial Information
- 6.2.3. Pharmaceutical Vials Portfolio
- 6.2.4. Recent Developments and Future Outlook
6.3. DWK Life Sciences
- 6.3.1. Company Overview
- 6.3.2. Pharmaceutical Vials Portfolio
- 6.3.3. Recent Developments and Future Outlook
6.4. Pacific Vial Manufacturing
- 6.4.1. Company Overview
- 6.4.2. Pharmaceutical Vials Portfolio
- 6.4.3. Recent Developments and Future Outlook
6.5. Thermo Fischer Scientific
- 6.5.1. Company Overview
- 6.5.2. Financial Information
- 6.5.3. Pharmaceutical Vials Portfolio
- 6.5.4. Recent Developments and Future Outlook
6.6. Worldwide Glass Resources
- 6.6.1. Company Overview
- 6.6.2. Pharmaceutical Vials Portfolio
- 6.6.3. Recent Developments and Future Outlook

7. COMPANY PROFILES: PHARMACEUTICAL VIAL MANUFACTURERS IN EUROPE

7.1. Chapter Overview
7.2. Gerresheimer
- 7.2.1. Company Overview
- 7.2.2. Financial Information
- 7.2.3. Pharmaceutical Vials Portfolio
- 7.2.4. Recent Developments and Future Outlook
7.3. Origin Pharma Packaging
- 7.3.1. Company Overview
- 7.3.2. Pharmaceutical Vials Portfolio
- 7.3.3. Recent Developments and Future Outlook
7.4. SCHOTT
- 7.4.1. Company Overview
- 7.4.2. Financial Information
- 7.4.3. Pharmaceutical Vials Portfolio
- 7.4.4. Recent Developments and Future Outlook
7.5. SGD Pharma
- 7.5.1. Company Overview
- 7.5.2. Financial Information
- 7.5.3. Pharmaceutical Vials Portfolio
- 7.5.4. Recent Developments and Future Outlook
7.6. Stevanato Group
- 7.6.1. Company Overview
- 7.6.2. Pharmaceutical Vials Portfolio
- 7.6.3. Recent Developments and Future Outlook

8. COMPANY PROFILES: PHARMACEUTICAL VIAL MANUFACTURERS IN ASIA PACIFIC

8.1. Chongqing Zhengchuan Pharmaceutical Packaging
- 8.1.1. Company Overview
- 8.1.2. Pharmaceutical Vials Portfolio
- 8.1.3. Recent Developments and Future Outlook
8.2. Danyang Xianghe Pharmaceutical Packaging
- 8.2.1. Company Overview
- 8.2.2. Pharmaceutical Vials Portfolio
- 8.2.3. Recent Developments and Future Outlook
8.3. Ningbo Zhengli Pharmaceutical Packaging
- 8.3.1. Company Overview
- 8.3.2. Pharmaceutical Vials Portfolio
- 8.3.3. Recent Developments and Future Outlook
8.4. Nipro
- 8.4.1. Company Overview
- 8.4.2. Financial Information
- 8.4.3. Pharmaceutical Vials Portfolio
- 8.4.4. Recent Developments and Future Outlook
8.5. Shandong Pharmaceutical Glass
- 8.5.1. Company Overview
- 8.5.2. Pharmaceutical Vials Portfolio
- 8.5.3. Recent Developments and Future Outlook

9. PARTNERSHIPS AND COLLABORATIONS

9.1. Chapter Overview
9.2. Partnership Models
9.3. Pharmaceutical Vials: List of Partnerships and Collaborations
- 9.3.1. Analysis by Year of Partnership
- 9.3.2. Analysis by Type of Partnership
- 9.3.3. Analysis by Year and Type of Partnership
- 9.3.4. Analysis by Type of Fabrication Material Used
- 9.3.5. Analysis by Sterilization Status
- 9.3.6. Analysis by Type of Partner
- 9.3.7. Most Active Players: Analysis by Number of Partnerships
- 9.3.8. Analysis by Geography
  - 9.3.8.1. Region-wise Distribution
  - 9.3.8.2. Country-wise Distribution

10. UPCOMING TRENDS IN PHARMACEUTICAL PACKAGING

10.1. Chapter Overview
10.2. Preference for Self-medication of Drugs, Through the Use of Modern Drug Delivery Devices
10.3. Development of Improved Packaging Components and Efforts to Optimize Manufacturing Costs
10.4. Availability of Modular Facilities
10.5. Growing Demand and Preference for Personalized Therapies
10.6. Rise in Provisions for Automating Fill / Finish Operations
10.7. Surge in Partnership Activity
10.8. Increase in Initiatives Undertaken by Industry Stakeholders in Developing Regions
10.9. Concluding Remarks

11. DEMAND ANALYSIS

11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Global Demand for Pharmaceutical Vials, Till 2035
- 11.3.1. Analysis by Type of Fabrication Material Used
  - 11.3.1.1. Global Demand for Pharmaceutical Glass Vials, Till 2035
  - 11.3.1.2. Global Demand for Pharmaceutical Plastic Vials, Till 2035
- 11.3.2. Analysis by Sterilization Status
  - 11.3.2.1. Global Demand for Unsterilized Pharmaceutical Vials, Till 2035
  - 11.3.2.2. Global Demand for Pre-sterilized Pharmaceutical Vials, Till 2035
- 11.3.3. Analysis by Geography
  - 11.3.3.1. Demand for Pharmaceutical Vials in North America, Till 2035
  - 11.3.3.2. Demand for Pharmaceutical Vials in Europe, Till 2035
  - 11.3.3.3. Demand for Pharmaceutical Vials in Asia Pacific, Till 2035
  - 11.3.3.4. Demand for Pharmaceutical Vials in Middle East and North Africa, Till 2035
  - 11.3.3.5. Demand for Pharmaceutical Vials in Latin America, Till 2035
  - 11.3.3.6. Demand for Pharmaceutical Vials in Rest of the World, Till 2035
11.4. Concluding Remarks

12. MARKET FORECAST AND OPPORTUNITY ANALYSIS

12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global Pharmaceutical Vials Market, Till 2035
- 12.3.1. Pharmaceutical Vials Market : Distribution by Type of Fabrication Material Used
  - 12.3.1.1. Pharmaceutical Glass Vials Market, Till 2035
  - 12.3.1.2. Pharmaceutical Plastic Vials Market, Till 2035
- 12.3.2. Pharmaceutical Vials Market : Distribution by Sterilization Status
  - 12.3.2.1. Unsterilized Pharmaceutical Vials Market, Till 2035
  - 12.3.2.2. Pre-sterilized Pharmaceutical Vials Market, Till 2035
- 12.3.3. Pharmaceutical Vials Market : Distribution by Geography
  - 12.3.3.1. Pharmaceutical Vials Market in North America, Till 2035
  - 12.3.3.2. Pharmaceutical Vials Market in Europe, Till 2035
  - 12.3.3.3. Pharmaceutical Vials Market in Asia Pacific, Till 2035
  - 12.3.3.4. Pharmaceutical Vials Market in Middle East and North Africa, Till 2035
  - 12.3.3.5. Pharmaceutical Vials Market in Latin America, Till 2035
  - 12.3.3.6. Pharmaceutical Vials Market in Rest of the World, Till 2035

13. CASE STUDY: ROBOTS IN PHARMACEUTICAL PACKAGING

13.1. Chapter Overview
13.2. Role of Robots in the Pharmaceutical Industry
- 13.2.1. Key Considerations for Selecting a Robotic System
- 13.2.2. Advantages of Robotic Systems
- 13.2.3. Disadvantages of Robotic Systems
13.3. Companies Providing Robots for Use in the Pharmaceutical Industry
13.4. Companies Providing Equipment Integrated with Robotic Systems for Pharmaceutical Packaging
- 13.4.1. Aseptic Technologies
- 13.4.2. AST
- 13.4.3. Bosch Packaging Technology
- 13.4.4. Dara Pharmaceutical Packaging
- 13.4.5. Fedegari Group
- 13.4.6. IMA
- 13.4.7. Steriline
- 13.4.8. Vanrx Pharmasystems

14. CASE STUDY: PRE-STERILIZED / READY-TO-USE PHARMACEUTICAL VIALS

14.1. Chapter Overview
14.2. Pharmaceutical Packaging and Filling
14.3. Limitations of Traditional Primary Packaging
14.4. Ready-to-Use Primary Packaging
- 14.4.1. Sterilization of Primary Packaging Material
  - 14.4.1.1. Sterilization Techniques
- 14.4.2. Advantages of Ready-to-Use Primary Packaging
- 14.4.3. Cost Saving Opportunities associated with Ready-To-Use Primary Packaging
- 14.4.4. Current Demand for Ready-To-Use Primary Packaging and Key Enablers
- 14.4.5. List of Pre-Sterilized / Ready-to-Use Pharmaceutical Vials
14.5. Concluding Remarks

15. CONCLUDING REMARKS

16. EXECUTIVE INSIGHTS

16.1. Chapter Overview
16.2. Company A
- 16.2.1. Company Snapshot
- 16.2.2. Interview Transcript: Business Development and Technology Director
16.3. Company B
- 16.3.1. Company Snapshot
- 16.3.2. Interview Transcript: Former Project Manager of Business Development
16.4. Company C
- 16.4.1. Company Snapshot
- 16.4.2. Interview Transcript: SiO2 Materials Science

17. APPENDIX 1: TABULATED DATA

18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

Product Code: RA100302

List of Tables

Table 3.1 Difference between Tubular and Moulded Glass Vials
Table 4.1 Pharmaceutical Vials: List of Products
Table 4.2 Pharmaceutical Vials: List of Manufacturers
Table 6.1 Leading Manufacturers of Pharmaceutical Vials in North America
Table 6.2 Corning: Company Snapshot
Table 6.3 Corning: Pharmaceutical Vials
Table 6.4 Corning: Recent Developments and Future Outlook
Table 6.5 DWK Life Sciences: Company Snapshot
Table 6.6 DWK Life Sciences: Pharmaceutical Vials
Table 6.7 DWK Life Sciences: Recent Developments and Future Outlook
Table 6.8 Pacific Vial Manufacturing: Company Snapshot
Table 6.9 Pacific Vial Manufacturing: Pharmaceutical Vials
Table 6.10 Thermo Fisher Scientific: Company Snapshot
Table 6.11 Thermo Fisher Scientific: Pharmaceutical Vials
Table 6.12 Thermo Fisher Scientific: Recent Developments and Future Outlook
Table 6.13 Worldwide Glass Resources: Company Snapshot
Table 6.14 Worldwide Glass Resources: Pharmaceutical Vials
Table 7.1 Leading Manufacturers of Pharmaceutical Vials in Europe
Table 7.2 Gerresheimer: Company Snapshot
Table 7.3 Gerresheimer: Pharmaceutical Vials
Table 7.4 Gerresheimer: Recent Developments and Future Outlook
Table 7.5 Origin Pharma Packaging: Company Snapshot
Table 7.6 Origin Pharma Packaging: Pharmaceutical Vials
Table 7.7 SCHOTT: Company Snapshot
Table 7.8 SCHOTT: Pharmaceutical Vials
Table 7.9 SCHOTT: Recent Developments and Future Outlook
Table 7.10 SGD Pharma: Company Snapshot
Table 7.11 SGD Pharma: Pharmaceutical Vials
Table 7.12 SGD Pharma: Recent Developments and Future Outlook
Table 7.13 Stevanato Group: Company Snapshot
Table 7.14 Stevanato Group: Pharmaceutical Vials
Table 7.15 Stevanato Group: Recent Developments and Future Outlook
Table 8.1 Leading Manufacturers of Pharmaceutical Vials in Asia Pacific
Table 8.2 Chongqing Zhengchuan Pharmaceutical Packaging: Company Snapshot
Table 8.3 Chongqing Zhengchuan Pharmaceutical Packaging: Pharmaceutical Vials
Table 8.4 DANYANG XIANGHE PHARMACEUTICAL PACKAGING: Company Snapshot
Table 8.5 DANYANG XIANGHE PHARMACEUTICAL PACKAGING: Pharmaceutical Vials
Table 8.6 Ningbo Zhengli Pharmaceutical Packaging: Company Snapshot
Table 8.7 Ningbo Zhengli Pharmaceutical Packaging: Pharmaceutical Vials
Table 8.8 Ningbo Zhengli Pharmaceutical Packaging: Recent Developments and Future Outlook
Table 8.9 Nipro: Company Snapshot
Table 8.10 Nipro: Pharmaceutical Vials
Table 8.11 Nipro: Recent Developments and Future Outlook
Table 8.12 Shandong Pharmaceutical Glass: Company Snapshot
Table 8.13 Shandong Pharmaceutical Glass: Pharmaceutical Vials
Table 9.1 Pharmaceutical Vials: Partnerships and Collaborations, Since 2015
Table 12.1 Tiered Pricing Structure of Prices of Pharmaceutical Vials across Different Geographies
Table 13.1 List of Pharmaceutical Robotics Manufacturers
Table 13.2 Aseptic Technologies: Company Overview
Table 13.3 Aseptic Technologies: Key Specifications of Crystal L1 Robot Line
Table 13.4 Aseptic Technologies: Key Specifications of Crystal SL1 Robot Line
Table 13.5 AST: Company Overview
Table 13.6 AST: Key Specifications of ASEPTiCell
Table 13.7 AST: Key Specifications of GENiSYS R
Table 13.8 AST: Key Specifications of GENiSYS C
Table 13.9 AST: Key Specifications of GENiSYS Lab
Table 13.10 Bosch Packaging Technology: Company Overview
Table 13.11 Bosch Packaging Technology: Key Specifications of ATO
Table 13.12 Dara Pharmaceutical Equipment: Company Overview
Table 13.13 Dara Pharmaceutical Equipment: Key Specifications of SYX-E Cartridge + RABS
Table 13.14 Fedegari Group: Company Overview
Table 13.15 Fedegari Group: Key Specifications of Fedegari Isolator
Table 13.16 IMA: Company Overview
Table 13.17 IMA: Key Specifications of INJECTA
Table 13.18 IMA: Key Specifications of STERI LIF3
Table 13.19 Steriline: Company Overview
Table 13.20 Steriline: Key Specifications of Robotic Nest Filling Machine
Table 13.21 Steriline: Key Specifications of Robotic Vial Filling Machine
Table 13.22 Steriline: Key Specifications of Robotic Vial Capping Machine
Table 13.23 Vanrx Pharmasystems: Company Overview
Table 13.24 Vanrx Pharmasystems: Key Specifications of Microcell Vial Filler
Table 13.25 Vanrx Pharmasystems: Key Specifications of SA25 Aseptic Filling Workcell
Table 14.1 Compatibility of Polymers with Ethylene Oxide Sterilization
Table 14.2 Advantages and Disadvantages of Different Sterilization Techniques
Table 14.3 List of Pre-sterilized / Ready-to-Use Pharmaceutical Vials
Table 16.1 Aseptic Technologies: Company Snapshot
Table 16.2 PYRAMID Laboratories: Company Snapshot
Table 16.3 SiO2 Materials Science: Company Snapshot
Table 17.1 Pharmaceutical Vials: Distribution by Type of Fabrication Material Used (Container)
Table 17.2 Pharmaceutical Vials: Distribution by Type of Fabrication Material Used (Closure)
Table 17.3 Pharmaceutical Vials: Distribution by Volume of Vial
Table 17.4 Pharmaceutical Vials: Distribution by Type of Vial Cap
Table 17.5 Pharmaceutical Vials: Distribution by Sterilization Status
Table 17.6 Pharmaceutical Vials: Distribution by Type of Product
Table 17.7 Pharmaceutical Vials: Distribution by Compatible Drug Class
Table 17.8 Pharmaceutical Vials: Distribution by Type of Formulation Stored
Table 17.9 Pharmaceutical Vials Manufacturers: Distribution by Year of Establishment
Table 17.10 Pharmaceutical Vials Manufacturers: Distribution by Company Size
Table 17.11 Pharmaceutical Vials Manufacturers: Distribution by Location of Headquarters
Table 17.12 Leading Manufacturers: Distribution by Number of Products
Table 17.13 Corning: Annual Revenues, Since 2016 (USD Billion)
Table 17.14 Thermo Fisher Scientific: Annual Revenues, Since 2016 (USD Billion)
Table 17.15 Gerresheimer: Annual Revenues, Since 2016 (EUR Billion)
Table 17.16 SCHOTT: Annual Revenues, Since 2016 (EUR Billion)
Table 17.17 Nipro: Annual Revenues, Since 2016 (JPY Billion)
Table 17.18 Partnerships and Collaborations: Cumulative Year-wise Trend, Since 2015
Table 17.19 Partnerships and Collaborations: Distribution by Type of Partnership
Table 17.20 Partnerships and Collaborations: Year-wise Trend by Type of Partnership
Table 17.21 Partnerships and Collaborations: Distribution by Type of Fabrication Material Used
Table 17.22 Partnerships and Collaborations: Year-wise Trend by Type of Fabrication Material Used
Table 17.23 Partnerships and Collaborations: Distribution by Sterilization Status
Table 17.24 Partnerships and Collaborations: Year-wise Trend by Sterilization Status
Table 17.25 Partnerships and Collaborations: Distribution by Analysis by Type of Partner
Table 17.26 Partnerships and Collaborations: Year-wise Trend by Analysis by Type of Partner
Table 17.27 Most Active Players: Distribution by Number of Partnerships
Table 17.28 Partnerships and Collaborations: Distribution by Region (Continent-wise)
Table 17.29 Partnerships and Collaborations: Distribution by Region (Country-wise)
Table 17.30 Global Demand for Pharmaceutical Vials, Till 2035 (Billion Units)
Table 17.31 Global Demand for Pharmaceutical Vials: Distribution by Type of Fabrication Material Used (Billion Units)
Table 17.32 Global Demand for Pharmaceutical Glass Vials, Till 2035 (Billion Units)
Table 17.33 Global Demand for Pharmaceutical Plastic Vials, Till 2035 (Billion Units)
Table 17.34 Global Demand for Pharmaceutical Vials: Distribution by Sterilization Status (Billion Units)
Table 17.35 Global Demand for Unsterilized Pharmaceutical Vials, Till 2035 (Billion Units)
Table 17.36 Global Demand for Pre-sterilized Pharmaceutical Vials, Till 2035 (Billion Units)
Table 17.37 Global Demand for Pharmaceutical Vials: Distribution by Geography
Table 17.38 Demand for Pharmaceutical Vials in North America, Till 2035 (Billion Units)
Table 17.39 Demand for Pharmaceutical Vials in Europe, Till 2035 (Billion Units)
Table 17.40 Demand for Pharmaceutical Vials in Asia Pacific, Till 2035 (Billion Units)
Table 17.41 Demand for Pharmaceutical Vials in Middle East and North Africa, Till 2035 (Billion Units)
Table 17.42 Demand for Pharmaceutical Vials in Latin America, Till 2035 (Billion Units)
Table 17.43 Demand for Pharmaceutical Vials in Rest of the World, Till 2035 (Billion Units)
Table 17.44 Global Pharmaceutical Vials Market, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.45 Pharmaceutical Vials: Likely Growth Scenarios
Table 17.46 Pharmaceutical Vials Market: Distribution by Type of Fabrication Material Used, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.47 Pharmaceutical Glass Vials Market, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.48 Pharmaceutical Plastic Vials Market, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.49 Pharmaceutical Vials Market: Distribution by Sterilization Status, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.50 Unsterilized Pharmaceutical Vials Market, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.51 Pre-sterilized Pharmaceutical Vials Market, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.52 Pharmaceutical Vials Market: Distribution by Geography, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.53 Pharmaceutical Vials Market in North America, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.54 Pharmaceutical Vials Market in Europe, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.55 Pharmaceutical Vials Market in Asia-Pacific, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.56 Pharmaceutical Vials Market in Middle East and North Africa, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.57 Pharmaceutical Vials Market in Latin America, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.58 Pharmaceutical Vials Market in Rest of the World, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)

List of Figures

Figure 3.1 Advantages of Pharmaceutical Packaging
Figure 3.2 Types of Pharmaceutical Packaging
Figure 3.3 Advantages of Glass Vials
Figure 3.4 Innovation in Pharmaceutical Packaging and Value Chain
Figure 4.1 Pharmaceutical Vials: Distribution by Type of Fabrication Material Used (Container)
Figure 4.2 Pharmaceutical Vials: Distribution by Type of Fabrication Material Used (Closure)
Figure 4.3 Pharmaceutical Vials: Distribution by Volume of Vial
Figure 4.4 Pharmaceutical Vials: Distribution by Type of Vial Cap
Figure 4.5 Pharmaceutical Vials: Distribution by Sterilization Status
Figure 4.6 Pharmaceutical Vials: Distribution by Type of Product
Figure 4.7 Pharmaceutical Vials: Distribution by Compatible Drug Class
Figure 4.8 Pharmaceutical Vials: Distribution by Type of Formulation Stored
Figure 4.9 Pharmaceutical Vials Manufacturers: Distribution by Year of Establishment
Figure 4.10 Pharmaceutical Vials Manufacturers: Distribution by Company Size
Figure 4.11 Pharmaceutical Vials Manufacturers: Distribution by Location of Headquarters
Figure 4.12 Leading Manufacturers: Distribution by Number of Products
Figure 5.1 Company Competitiveness Analysis: Small Manufacturers
Figure 5.2 Company Competitiveness Analysis: Mid-sized Manufacturers
Figure 5.3 Company Competitiveness Analysis: Large Manufacturers
Figure 5.4 Company Competitiveness Analysis: Very Large Manufacturers
Figure 6.1 Corning: Annual Revenues, Since 2016 (USD Billion)
Figure 6.2 Thermo Fisher Scientific: Annual Revenues, Since 2016 (USD Billion)
Figure 7.1 Gerresheimer: Annual Revenues, Since 2016 (EUR Billion)
Figure 7.2 SCHOTT: Annual Revenues, Since 2016 (EUR Billion)
Figure 8.1 Nipro: Annual Revenues, Since 2016 (JPY Billion)
Figure 9.1 Partnerships and Collaborations: Cumulative Year-wise Trend, Since 2015
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Year-wise Trend by Type of Partnership
Figure 9.4 Partnerships and Collaborations: Distribution by Type of Fabrication Material Used
Figure 9.5 Partnerships and Collaborations: Year-wise Trend by Type of Fabrication Material Used
Figure 9.6 Partnerships and Collaborations: Distribution by Sterilization Status
Figure 9.7 Partnerships and Collaborations: Year-wise Trend by Sterilization Status
Figure 9.8 Partnerships and Collaborations: Distribution by Analysis by Type of Partner
Figure 9.9 Partnerships and Collaborations: Year-wise Trend by Analysis by Type of Partner
Figure 9.10 Most Active Players: Distribution by Number of Partnerships
Figure 9.11 Partnerships and Collaborations: Distribution by Region (Continent-wise)
Figure 9.12 Partnerships and Collaborations: Distribution by Region (Country-wise)
Figure 10.1 Upcoming Trends Related to Pharmaceutical Packaging
Figure 10.2 Future Growth Opportunities of Innovative Pharmaceutical Packaging based on Recent Trends
Figure 11.1 Global Demand for Pharmaceutical Vials, Till 2035 (Billion Units)
Figure 11.2 Global Demand for Pharmaceutical Vials: Distribution by Type of Fabrication Material Used (Billion Units)
Figure 11.3 Global Demand for Pharmaceutical Glass Vials, Till 2035 (Billion Units)
Figure 11.4 Global Demand for Pharmaceutical Plastic Vials, Till 2035 (Billion Units)
Figure 11.5 Global Demand for Pharmaceutical Vials: Distribution by Sterilization Status (Billion Units)
Figure 11.6 Global Demand for Unsterilized Pharmaceutical Vials, Till 2035 (Billion Units)
Figure 11.7 Global Demand for Pre-sterilized Pharmaceutical Vials, Till 2035 (Billion Units)
Figure 11.8 Global Demand for Pharmaceutical Vials: Distribution by Geography
Figure 11.9 Demand for Pharmaceutical Vials in North America, Till 2035 (Billion Units)
Figure 11.10 Demand for Pharmaceutical Vials in Europe, Till 2035 (Billion Units)
Figure 11.11 Demand for Pharmaceutical Vials in Asia Pacific, Till 2035 (Billion Units)
Figure 11.12 Demand for Pharmaceutical Vials in Middle East and North Africa, Till 2035 (Billion Units)
Figure 11.13 Demand for Pharmaceutical Vials in Latin America, Till 2035 (Billion Units)
Figure 11.14 Demand for Pharmaceutical Vials in Rest of the World, Till 2035 (Billion Units)
Figure 12.1 Global Pharmaceutical Vials Market, Till 2035 (USD Billion)
Figure 12.2 Pharmaceutical Vials: Likely Growth Scenarios
Figure 12.3 Pharmaceutical Vials Market : Distribution by Type of Fabrication Material Used (USD Billion)
Figure 12.4 Pharmaceutical Glass Vials Market, Till 2035 (USD Billion)
Figure 12.5 Pharmaceutical Plastic Vials Market, Till 2035 (USD Billion)
Figure 12.6 Pharmaceutical Vials Market : Distribution by Sterilization Status (USD Billion)
Figure 12.7 Unsterilized Pharmaceutical Vials Market, Till 2035 (USD Billion)
Figure 12.8 Pre-sterilized Pharmaceutical Vials Market, Till 2035 (USD Billion)
Figure 12.9 Pharmaceutical Vials Market : Distribution by Geography (USD Billion)
Figure 12.10 Pharmaceutical Vials Market in North America, Till 2035 (USD Billion)
Figure 12.11 Pharmaceutical Vials Market in Europe, Till 2035 (USD Billion)
Figure 12.12 Pharmaceutical Vials Market in Asia-Pacific, Till 2035 (USD Billion)
Figure 12.13 Pharmaceutical Vials Market in Middle East and North Africa, Till 2035 (USD Billion)
Figure 12.14 Pharmaceutical Vials Market in Latin America, Till 2035 (USD Billion)
Figure 12.15 Pharmaceutical Vials Market in Rest of the World, Till 2035 (USD Billion)
Figure 13.1 Key Considerations for Selecting a Robotic System
Figure 13.2 Advantages Associated with Use of Robotic Systems in Pharmaceutical Manufacturing
Figure 14.1 Traditional Aseptic Pharmaceutical Filling
Figure 14.2 Ready-to-Use Enabled Flexible, Aseptic Processing
Figure 14.3 Advantages of Ready-to-Use Platform
Figure 14.4 Cost Comparison of Ready-to-Use and Conventional Container Systems
Figure 14.5 Drivers of Ready-to-Use Platform
Figure 16.1 Concluding Remarks: Overall Market Landscape
Figure 16.2 Concluding Remarks: Partnerships and Collaborations
Figure 16.3 Concluding Remarks: Global Demand for Pharmaceutical Vials
Figure 16.4 Concluding Remarks: Market Forecast

Pharmaceutical Vials Market: Industry Trends and Global Forecasts - Distribution by Type of Fabrication Material Used, Sterilization Status and Key Geographies

Description

Table of Contents

List of Tables

PHARMACEUTICAL VIALS MARKET: OVERVIEW

PHARMACEUTICAL VIALS MARKET: GROWTH AND TRENDS

PHARMACEUTICAL VIALS MARKET: KEY INSIGHTS

Example Players in the Pharmaceutical Vials Market

PHARMACEUTICAL VIALS MARKET: RESEARCH COVERAGE

KEY QUESTIONS ANSWERED IN THIS REPORT

REASONS TO BUY THIS REPORT

ADDITIONAL BENEFITS

TABLE OF CONTENTS

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. MARKET LANDSCAPE

5. COMPANY COMPETITIVENESS ANALYSIS

6. COMPANY PROFILES: PHARMACEUTICAL VIAL MANUFACTURERS IN NORTH AMERICA

7. COMPANY PROFILES: PHARMACEUTICAL VIAL MANUFACTURERS IN EUROPE

8. COMPANY PROFILES: PHARMACEUTICAL VIAL MANUFACTURERS IN ASIA PACIFIC

9. PARTNERSHIPS AND COLLABORATIONS

10. UPCOMING TRENDS IN PHARMACEUTICAL PACKAGING

11. DEMAND ANALYSIS

12. MARKET FORECAST AND OPPORTUNITY ANALYSIS

13. CASE STUDY: ROBOTS IN PHARMACEUTICAL PACKAGING

14. CASE STUDY: PRE-STERILIZED / READY-TO-USE PHARMACEUTICAL VIALS

15. CONCLUDING REMARKS

16. EXECUTIVE INSIGHTS

17. APPENDIX 1: TABULATED DATA

18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Tables

List of Figures